- +852 4750 3485
- info@mycancerinfo.org
Evidence-based guides to vitamins, minerals, herbal supplements, and sports nutrition—no hype, just facts.
Nivolumab is an immunotherapy medication used in melanoma, lung cancer, kidney cancer, and other malignancies.
It is also a PD-1 immune checkpoint inhibitor, similar to pembrolizumab.
Nivolumab works by enhancing the activity of the immune system against cancer cells by blocking inhibitory signals. This may allow immune cells to better identify and destroy cancer cells.
As with other immunotherapies, increased immune activity may also affect normal organs, and monitoring for immune-related effects is important.
本内容仅供教育与资讯参考之用，不构成医疗建议、诊断或治疗方案。不同患者的癌症情况与护理方向均可能存在差异，开始任何新的护理方案、营养补充或相关安排前，请先咨询医生或合资格的专业医疗人员。本文不保证任何结果，个人反应与情况亦可能有所不同。
Learn how precision medicine can help with your cancer treatment
The effectiveness of cancer treatment varies among each patient.
